Part of our AI Trading ecosystem
AI Trading Tool
The main AI trading tool page
AI Stock Analysis
4,600+ stocks analyzed
AI Stock Picks
Daily AI-generated picks
AI Stock Picker
Scan the universe for ideas
Stock Recommendations
Ranked AI research ideas
AI Trading Signals
Real-time momentum alerts
AI Stock Screener
Scan 4,600+ stocks live
Best AI Trading Tools
#1 pick: Stockinhood
How AI Trading Works
The technology explained
AI Stock Predictions
Multi-timeframe targets
$13.94
Current Price
$1.50B
Market Cap
-202.2
P/E Ratio
$14.47
52W High
$9.95
52W Low
CEO
Mike Nolan
Employees
363
Year Founded
2014
Headquarters
Brisbane, California
Sector / Industry
Healthcare · Diagnostics & Research
Market Cap
$1.50B
Today's High
$14.34
Today's Low
$13.76
Open
$14.09
Previous Close
$13.94
52-Week High
$14.47
52-Week Low
$9.95
Today's Volume
348,703
Avg. Volume
871,720
Overnight Volume
13,600
Shares Outstanding
107,600,000
P/E Ratio
-202.15
EPS
$-8.47
Beta
1.25
Dividend Yield
0.00%
Live market stats are a premium feature
These stats are from a cached snapshot. Unlock real-time data with lifetime access — $19.99.
Quarterly expected vs. actual performance
| Quarter | Date | EPS Est. | EPS Actual | Surprise | Rev. Est. | Rev. Actual |
|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.45 | -0.42 | +7% | $0.5M | $0.6M |
| Q1 2026 | 2026-05-14 | -0.50 | -0.55 | -10% | $0.4M | $0.3M |
| Q4 2025 | 2026-02-18 | -0.60 | -0.58 | +3% | $0.2M | $0.25M |
| Q3 2025 | 2025-11-12 | -0.65 | -0.70 | -8% | $0.1M | $0.08M |
Earnings data is AI-compiled from public sources and may be delayed or approximate. Not financial advice.
Price History
Freenome (FRNM) has demonstrated significant momentum following its public debut via merger with Perceptive Capital Solutions in July 2026. The company's multiomics platform for early cancer detection received a major boost with the FDA approval of its SimpleScreen™ CRC blood-based test in late July 2026, supported by a commercialization partnership with Abbott. While the company remains in a high-growth, pre-profitability phase with a negative P/E ratio, analyst consensus is unanimously bullish with a price target of $18.00. Technical indicators suggest a 'Strong Buy' signal as the stock trades near its 52-week highs. Investors should weigh the clinical success against the high cash burn typical of the biotechnology sector.
7-Day Target
$15.25
30-Day Target
$16.80
6-Month Target
$18.00
AI Confidence
Risk Level
High
Analyst Target
$17.5
FRNM is well-positioned to benefit from a stable regional deposit base and consistent loan growth within its local Virginia markets. Improving net interest margins and prudent cost management could drive significant earnings per share growth as interest rate volatility subsides.
The bank faces headwinds from a high-interest-rate environment that pressures deposit costs and limits net interest income expansion. Additionally, potential credit quality deterioration in its commercial real estate portfolio poses a threat to profitability if the economic climate weakens.
First National Corporation (FRNM) is a financial holding company providing a range of banking and financial services through its subsidiary, First Bank. Based in Virginia, the company focuses on community-oriented commercial and consumer banking products.
Unlock unlimited AI stock analysis, market signals, and daily briefings for a one-time payment of $19.99.
30-day money-back guarantee • Secure payment by Square
Stockinhood's AI generates multi-timeframe price targets for FRNM (Freenome Holdings Inc.), including 7-day, 30-day, and 6-month outlooks based on market data, technical indicators, and news sentiment. These estimates are for informational purposes only and do not constitute financial advice.
Our AI assigns a sentiment signal (Bullish, Bearish, or Neutral) to FRNM based on multiple factors including price trends, momentum, and market conditions. The current AI signal is Bullish. This is AI-generated research, not financial advice — always consult a licensed advisor before investing.
The AI-generated price target for FRNM is based on multi-timeframe analysis and represents a hypothetical scenario, not a guarantee. The current price is $13.94. Price targets are educational estimates and should not be relied upon for investment decisions.
Exposure to commercial real estate volatility Pressure on net interest margins due to competitive deposit pricing Heightened regulatory compliance costs Interest rate risk affecting asset valuations All risk analysis is informational only and not financial advice.
Freenome Holdings Inc. (FRNM) operates in the Healthcare sector, specifically the Diagnostics & Research industry. This classification helps investors understand the company's business focus and compare it with peers in the same sector.
AI Stock Analysis
AI research on 4,600+ stocks
Best AI Trading Tools
15 AI trading tools tested & compared
Stock Analysis
Browse 7,700+ AI stock predictions
Financial Blog
AI-generated market insights daily
Financial Glossary
40+ stock market terms defined
Free Calculators
Position size, dividend yield & risk-reward tools
Original Research
Citable AI stock-market data studies
Social Buzz
Real-time social sentiment tracking